Xiaolong Liu

1.3k total citations · 1 hit paper
6 papers, 888 citations indexed

About

Xiaolong Liu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaolong Liu has authored 6 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Xiaolong Liu's work include Cancer, Hypoxia, and Metabolism (2 papers), Cancer-related molecular mechanisms research (2 papers) and MicroRNA in disease regulation (2 papers). Xiaolong Liu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Cancer-related molecular mechanisms research (2 papers) and MicroRNA in disease regulation (2 papers). Xiaolong Liu collaborates with scholars based in China. Xiaolong Liu's co-authors include Kun Zhou, Jingbo Sun, Liang Li, Zhicheng Zeng, Wenting Liao, Yanqing Ding, Xiaoli Ren, Fuyao Song, Xiao-Liang Lan and Guoxin Li and has published in prestigious journals such as Nature Communications, Scientific Reports and Cancer Cell International.

In The Last Decade

Xiaolong Liu

5 papers receiving 885 citations

Hit Papers

Cancer-derived exosomal miR-25-3p promotes pre-metastatic... 2018 2026 2020 2023 2018 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolong Liu China 4 732 590 134 107 92 6 888
Yanzi Gu China 8 669 0.9× 486 0.8× 180 1.3× 93 0.9× 246 2.7× 13 876
Bangrong Cao China 14 564 0.8× 376 0.6× 167 1.2× 123 1.1× 133 1.4× 44 818
Fuyao Song China 8 1.2k 1.6× 900 1.5× 321 2.4× 132 1.2× 162 1.8× 9 1.4k
Enhao Zhao China 16 412 0.6× 335 0.6× 162 1.2× 101 0.9× 196 2.1× 25 715
Yusheng Lin China 13 547 0.7× 317 0.5× 152 1.1× 74 0.7× 148 1.6× 23 733
Hiroko Tadokoro Japan 6 774 1.1× 620 1.1× 61 0.5× 31 0.3× 93 1.0× 6 887
Simon Lavotshkin United States 5 355 0.5× 236 0.4× 227 1.7× 64 0.6× 110 1.2× 8 589
Guixing Jiang China 14 489 0.7× 346 0.6× 139 1.0× 55 0.5× 114 1.2× 26 676
Yi Ba China 11 503 0.7× 322 0.5× 98 0.7× 27 0.3× 119 1.3× 23 665

Countries citing papers authored by Xiaolong Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Liu more than expected).

Fields of papers citing papers by Xiaolong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Liu. The network helps show where Xiaolong Liu may publish in the future.

Co-authorship network of co-authors of Xiaolong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Liu. A scholar is included among the top collaborators of Xiaolong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Liu. Xiaolong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Hu, Ming, et al.. (2025). Knockdown of CCNB2 inhibits the tumorigenesis of gastric cancer by regulation of the PI3K/Akt pathway. Scientific Reports. 15(1). 5703–5703. 2 indexed citations
2.
3.
Liu, Lixin, Xiaoli Ren, Zhicheng Zeng, et al.. (2020). GFPT2 promotes metastasis and forms a positive feedback loop with p65 in colorectal cancer.. PubMed. 10(8). 2510–2522. 17 indexed citations
4.
Sun, Jingbo, Lan Jin, Kun Zhou, et al.. (2019). Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer. Cancer Cell International. 19(1). 264–264. 120 indexed citations
5.
Liu, Xiaolong, et al.. (2019). Expression of miRNA-146b-5p in patients with thyroid cancer in combination with Hashimoto's disease and its clinical significance. Oncology Letters. 17(6). 4871–4876. 11 indexed citations
6.
Zeng, Zhicheng, Yuling Li, Xiao-Liang Lan, et al.. (2018). Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nature Communications. 9(1). 5395–5395. 738 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026